Complaints sent to the device manufacturer said there is an increased incidence of the Sheridan connector becoming disconnected from the endotracheal tube, which may result in the patient not obtaining sufficient oxygen.
The FDA has classified the recall as a Class 1, defined as a situation where the product will cause serious adverse health consequences or death.
Teleflex said customers who have the affected product should immediately discontinue use and return it.
Access the list of affected products here.
More articles on supply chain:
Blood shortage spurs rationing, threatens patient care in Southern hospitals
How 2 health systems are moving the needle on costs & outcomes with an optimized supply chain
FDA recalls 3 blood test analyzers
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
